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1. Introduction
The yeast Candida auris is a relatively new 
pathogen that was first isolated in 2009 
from a Japanese patient.[1] It causes severe 
invasive infections in hospitalized patients, 
which lead to high mortality rates between 
35% and 60%.[2,3] Resistance against fungi-
cides such as polyenes and azoles imposes 
an additional threat[4] and transmission 
between patients and the environment 
can lead to a spread of the pathogen also 
in care units.[5] Therefore, the Centers for 
Disease Control and Prevention released 
a clinical alert in June 2016,[6] initiating a 
broad public discourse, identifying C. auris 
as an emerging “superbug.”[7] As conven-
tional treatments with antifungal drugs 
fail due to the multidrug resistance of 
C. auris, antimicrobial peptides (AMP) can 
be regarded as promising alternative fun-
gicides. AMPs reduce structural integrity 
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of the cell walls of these pathogens by physical disintegration 
and/or pore formation and they are expected to provide treat-
ment options even against organisms resistance to conventional 
antifungal drugs that typically address distinct target structure 
(e.g., surface proteins, enzymes, etc.).[8,9] However, the thera-
peutic potential of AMPs has been limited by their considerable 
toxicities also toward human cells.[10] The AMP Cm-p5 derived 
from a peptide isolated from the coastal mollusk Cenchritis 
muricatus represents an exception as the AMP exhibited effi-
cient antifungal activity against C. albicans, C. parapsilosis, 
Cryptococcus neoformans, and Trichophyton rubrum with only 
negligible toxicity toward mammalian cells.[11,12] Therefore, 
Cm-p5 provides an attractive therapeutic index opening various 
opportunities for developing efficient and safe antifungal drugs 
also against C. auris infections, such as wound protections after 
initial contamination.[12] In order to receive effective AMP drugs 
for applications in wound care, there is an urgent demand to 
deliver these peptides to the wound or site of infection in a safe 
and convenient manner. Hydrogels have been recognized as 
material of choice for wound dressings, since they are optimal 
regulators of moisture and can create positive environments for 
wound healing.[13,14] As so-called “active” dressings, functional 
hydrogels are produced and marketed supplying additional fea-
tures beyond simple moisture control to further support and 
improve the healing process. Next-generation hydrogels pro-
mote regeneration of damaged tissues, they serve as efficient 
anti-infectives against multidrug-resistant pathogens,[15] or they 
also allow monitoring of the healing process.[13] AMPs have 
been loaded into hydrogels for topical applications[16,17] on the 
wound surface at the infection site and to achieve first line of 
defense against fatal wound infections, for example, for applica-
tions in intensive care units and after surgery of contaminated 
patients. The mannose-specific lectin B (LecB) as a tetrameric 
protein providing four binding sites toward sugar residues 
on the surface of bacteria and higher cells[18,19] has already 
been used to bind and immobilize carbapenem-resistant 
Pseudomonas aeruginosa within a hydrogel matrix that were sub-
sequently eradicated by the respective AMPs.[15]
Inspired by Cerberus, the three-headed gatekeeper dog of the 
underworld Hades in the Greek mythology, which prevented 
souls from migration into the Hades or out of it, we have devel-
oped a multicomponent sandwich hydrogel matrix consisting of 
a protein hydrogel acting as a carrier subsequently coated with 
LecB for quantitative immobilization of C. auris cells creating 
a dedicated affinity layer on the surface of the carrier hydrogel. 
The second hydrogel layer consists of a fibrillary hydrogel 
serving as a reservoir for the anti-Candida peptide, Cm-p5, to 
allow effective elimination of this emerging pathogenic yeast 
after its binding to the affinity layer. Amino acid-based fibril-
lary hydrogels, such as the Fmoc-Met-OH hydrogel, are ideally 
suited because gelation occurs under gentle and physiological 
conditions by self-assembly instead of chemical cross-linking 
and thus without undesired covalent and irreversible immo-
bilization of the peptide,[20] although covalent attachment to a 
surface has been described as a technology to realize antimi-
crobial coatings.[21] Our system is composed of two different 
hydrogel layers in the millimeter range of thickness (3.5 mm); 
however, including the LecB coating as an affinity layer, it com-
prises three functionalities: 1) a drug reservoir for storage of 
AMP and 2) a stabilizing carrier layer including the surface 
affinity layer for immobilization of the pathogen. We envision 
an efficient and safe hydrogel treatment against severe wound 
infections often observed in hospitals that are safe, convenient, 
and efficient to use against pathogens where currently no 
medication exists.
2. Results and Discussion
2.1. Multicomponent Hydrogel
The two-layer sandwich hydrogel matrix was composed of a 
bovine serum albumin (BSA)-based protein hydrogel and a 
second layer consisted of fibrillary hydrogel made from methio-
nine, which is protected by fluorenylmethyloxycarbonyl protec-
tion group (Fmoc-Met-OH) (Figure 1A).
2.1.1. Drug Reservoir Layer
The Fmoc-Met-OH hydrogel on the other hand was prepared 
by spontaneous fibril formation by self-assembly upon mixing 
Fmoc-Met-OH solution in dimethyl sulfoxide (DMSO) with 
phosphate-buffered saline (PBS) containing the desired concen-
trations of Cm-p5 as an AMP[20,22] (Figure 1A, “drug reservoir 
layer”). The dilution lowers the DMSO concentration to 12.5% 
v/v and thus below toxicological concentration since DMSO is 
regarded as pharmaceutically active at concentrations between 
60% and 90% for topical application.[23] The sandwich resulting 
from these two different hydrogels can simply be formed by 
either precasting the Fmoc-Met-OH hydrogel and overlaying 
it with the protein hydrogel or vice versa mediated by its 
self-adhesive properties.
2.1.2. Carrier Layer Including the Affinity Layer
The protein hydrogel linker tetrakis-(hydroxymethyl)phos-
phonium-chloride (THPC) has been suggested in a three-step 
reaction mechanism via formation of formaldehyde,[24] an 
amine-formaldehyde reaction to yield an immonium ion in 
a Mannich-type reaction, and its final coupling by the phos-
phorus immonium ion reaction (Figure 1A, “hydrogel carrier 
layer”). After the preparation of the two layers, the affinity layer 
was created by maleimide cross-linker-mediated decoration 
of the carrier layer with LecB (YFP-LecB) (Figure 1A, “affinity 
layer”). To gain full functionality, the AMP Cm-p5 (Figure 1B) 
as the pharmacological active compound was included during 
the self-assembly process of the Fmoc-Met-OH reservoir layer. 
The macroscopic and microscopic structure of the resulting 
material was analyzed (Figure 2A–C).
2.2. Characterization of the Multicomponent Hydrogel
The curve progression during BSA/THPC hydrogel gelation 
time appeared to be significantly different from that of a typical 
one-step cross-linking reaction. As THPC exposes four reactive 
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groups,[24] the cross-linking appears to takes place as a reaction 
of higher order involving at least four major steps, explaining 
the complex progression of the measured storage and loss 
moduli. Nevertheless, the BSA/THPC hydrogel thereby reached 
a manageable stability after around 50 min, although the cross-
linking was still not complete (Figure 2D). A linear fit of data 
after 79 min indicated that the cross-linking was still in progress 
with 2.85 Pa s−1 after this timepoint. For this reason, hydrogels 
used for the two-layer hydrogel system were prepared at least 
16 h before their usage to assure fully cross-linked hydrogel 
systems of high stability and reproducibility. Gel formation of 
the fibrillary Fmoc-Met-OH hydrogel proceeds via noncova-
lent interactions,[22] during dilution of the monomeric com-
pound dissolved in pure DMSO into phosphate-buffered saline 
(PBS). Gel formation occurs instantaneously by self-assembly, 
reaching a stable maximum within 5 min (Figure 2E).
The BSA/THPC hydrogel showed the highest storage mod-
ulus under these conditions and remained stable until a shear 
strain of 43.6% (as determined from the crossover points of the 
loss modulus and the storage modulus, not shown). The Fmoc-
Met-OH hydrogel itself, however, revealed a lower storage mod-
ulus and remained stable until a shear strain of 5%. As expected, 
the sandwich of the two layers of hydrogels showed a storage 
modulus intermediate to its individual components, respectively, 
and remained stable until a shear strain of 6.4% (Figure 2F), 
which is in the range of human skin, muscle tissue, or wound 
dressings based on bacterial cellulose.[25–27] These findings 
were also supported by cryo scanning electron microscopy. The 
Macromol. Biosci. 2020, 2000005
Figure 1. Preparation of BSA/THPC-Fmoc-Met-OH composite hydrogels. A) Protein hydrogel was prepared from BSA by cross-linking with the four-
armed amino-reactive THPC. THPC has been suggested in a three-step reaction mechanism via formation of formaldehyde, an amine-formaldehyde 
reaction to yield an immonium ion in a Mannich-type reaction, and its final coupling through the phosphorus immonium ion reaction. The second 
hydrogel layer was prepared from Fmoc-protected methionine (Fmoc-Met-OH) by immediate dilution of Fmoc-Met-OH stock solution in DMSO into 
PBS containing Cm-p5 as an AMP. The protein hydrogel layer was decorated with lectin B by adding thiol-specific maleimide cross-linker bismaleimi-
doethane (BMOE). B) chemical structure of Cm-p5 (left) and ball-stick representation of its 3D structure derived from PDB:2MP9.
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BSA/THPC hydrogel (Figure 2B) showed a smooth, even surface 
with small pores with an average pore diameter of 66 ± 7 nm 
(investigated by FIJI software[28]), explaining its rigidity and sta-
bility in the rheological analysis. In contrast, a branched fibril-
lary structure typical for Fmoc amino acid-based hydrogels[20] 
was found for the Fmoc-Met-OH layer building an architecture 
with cavities orders of magnitudes larger compared to those of 
the BSA/THPC hydrogel layer (Figure 2C). The larger cavities 
may already be sufficient to explain the different mechanical 
properties including the low-storage modulus of the Fmoc-Met-
OH layer since pore sizes have a significant impact on the sta-
bility of hydrogels.[29] In summary, the BSA/THPC hydrogel, 
which was later used for the decoration with lectin as affinity 
or adapter molecules to mediate yeast-binding properties to the 
hydrogel surface, additionally provides an increase of stability to 
the fibrillary hydrogel, making it easier to handle. The two-layer 
hydrogel remained stable without rupture even after bending to 
180° (Figure 3A), suggesting it is suitable for application as a 
wound dressing, which has to withstand the impact of different 
forces upon human movement. The two-layer hydrogel also 
showed adhesive properties to pork skin and could be removed 
residue free. The zone of adhesion thereby also showed the pos-
itive moisturizing effect of the hydrogel (Figure 3B). Although 
the adhesive properties are beneficial for the wound dressing, 
a fixing bandage would be used in any case of a real wound 
treatment.
2.3. Diffusion Analysis
A crucially important feature of the two-layer sandwich 
hydrogel is its ability to store and release drug molecules 
Macromol. Biosci. 2020, 2000005
Figure 2. Characterization of the composite hydrogel systems. A) Polymerization was visualized by the vial inversion assay of the carrier layer (I) alone, 
drug reservoir layer alone (II), and subsequent casting of I onto II (III). The carrier layer was stained with bromophenol blue for better visibility. Patches 
of the hydrogel sandwich have a diameter of 2.3 cm and a thickness of 3.5 mm. Cryo-scanning electron microscopy of the individual composite material 
layers reveals a porous structure for the B) BSA/THPC-hydrogel and a fibrillary structure for the C) Fmoc-Met-OH hydrogel. Rheological characteriza-
tion of the composite hydrogel systems: D) Polymerization of a BSA/THPC hydrogel (carrier layer) monitored through the increase of elastic shear 
modulus; blue color denotes the loss modulus (G″), whereas black color denotes the storage modulus (G′). E) Polymerization of an Fmoc-Met-OH 
hydrogel (drug reservoir layer) monitored through the increase of elastic shear modulus, blue color denotes the loss modulus (G″), whereas black color 
denotes the storage modulus (G′). F) Comparison of elastic shear moduli of BSA/THPC hydrogel (black), unloaded (blue) and loaded Fmoc-Met-OH 
hydrogels (red, dotted), and the composite material (green) after complete polymerization. Error bars represent standard deviations of experiments 
conducted in triplicates.
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from the fibrillary network serving as a reservoir for releasing 
molecules into the protein hydrogel and into the environ-
ment (i.e., an infected wound). Therefore the carrier hydrogel 
was prepared in a 3D printed casting mold (Figure 4A). The 
resulting cavities were filled with the Fmoc-Met-OH hydrogel 
to generate drug reservoir gel inlays in the material (Figure 4B). 
The diffusion within the carrier layer was investigated with a 
rhodamine B-loaded reservoir, as amphiphilic model chemical 
compound.[12,30] Confocal laser scanning microscopy revealed 
an even distribution of rhodamine B in the BSA/THPC 
hydrogel after manufacturing and loading (Figure 4C). Quanti-
tative analysis of fluorescence within the BSA/THPC hydrogel 
thereby reveals the penetration of the carrier layer from the 
reservoir layer at a rate of 2.35% min−1 until an equilibrium is 
reached 60 min after loading (Figure 4D). This fast and even 
distribution during the fabrication process of the two-layer 
sandwich hydrogel system is important for later industrial 
production processes. This easy loading ensures a homoge-
neously drug preloaded affinity layer with instant pharmaco-
logical effect for a convenient topical application of the wound 
dressing material.
The release from the wound dressing material was inves-
tigated in the two-layer hydrogel system, in which several 
carrier layers were tested with different BSA concentrations. 
The release reaches individual equilibria for the different gel 
concentrations (Figure 4E), suggesting that the release can be 
controlled by the BSA concentration used. However, all hydro-
gels showed a burst release within 5 h independent from the 
BSA concentration used (Figure 4F). Since the overall hard-
ness of the composite material mainly depends on the elastic 
properties of the carrier layer (Figure 2F) and thus on the BSA 
concentration.[29,31] This promises that the mechanical proper-
ties of the intended final wound dressing can be tuned, without 
disturbing the burst release of an encapsulated drug, necessary 
for a convenient fast active treatment. The release rate of the 
10% BSA hydrogel as a prototype reached its maximum within 
the first 2 h (Figure 4G), resulting in an almost complete release 
of the compound. In addition to the mentioned mechanical 
tunability, its capability for immediate delivery of antimicrobial 
drugs qualifies the composite as a potent material since imme-
diate clearing of pathogens from infected wounds appears to be 
most critical after changing the surgical dressing to minimize 
the risk of deadly systemic infections for the patient.
2.4. Immobilization of Pathogenic Yeast Cells
The immobilization of pathogens within the hydrogel material 
was accomplished via a recombinant fusion between lectin and 
yellow fluorescent protein (YFP) as a reporter protein domain.[15] 
The purified YFP-LecB fusion protein was fully functional in 
binding C. auris and thus labeling the cells for fluorescence 
microscopy (Figure 5A). The BSA/THPC hydrogel, whose prop-
erties can easily be tailored and which has been shown to be 
biocompatible,[29,31] was decorated with recombinant YFP-LecB 
by chemical cross-linking[15] using bismaleimideoethane with 
fluorescence signals of the labeled material linear increasing 
with YFP-LecB concentrations and resulting in homogenous 
functionalization of the material (Figure 5B). The increasing 
YFP-LecB coverage was almost identical with an increase of 
binding capacity of the YFP-LecB hydrogel for C. auris reaching 
a complete coverage of approximately 90 000 cells mm−2 at lectin 
concentrations of 300 × 10−9 m, which is in accordance with the 
calculated value for the maximal coverage of 90 000 cells mm2 
taking an average yeast diameter of 3–4 µm into account[4] 
(Figure 5C,D). These findings constitute conclusive evidence that 
the BSA/THPC hydrogel layer can be decorated with YFP-LecB, 
which in turn binds and thus captures C. auris by the binding of 
carbohydrates on the surface of the cells.[32,33]
Based on cell density measurements, the minimal inhibi-
tory concentration (MIC) was derived from a Lambert–
Pearson plot[34] and found to be 11 µg of Cm-p5 per milliliter 
(Figure 6A), which is in a similar range as observed for other 
Candida species previously.[12] Cm-p5 also remained active 
in samples containing increasing concentrations of human 
blood serum incubated for 6 or 12 h, despite a nonsignificant 
decrease at 75% v/v blood serum (Figure 6B). Although wound 
exudate contains less proteins than blood serum, proteases are 
Macromol. Biosci. 2020, 2000005
Figure 3. Flexibility and adhesion of the multicomponent hydrogel. The carrier layer was stained with bromophenol blue for better visualization. 
A) Bending of a multicomponent hydrogel from 0° to 180°. B) Multicomponent hydrogel adhering to pork skin directly after application (0 h). Adhe-
sion- and residue-free peeling off of the multicomponent hydrogel after 24 h. The dotted black circle indicates the area of application, which showed 
the moisturizing effect of the hydrogel.
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also present in significant amounts[35] qualifying blood serum 
as a not ideal but reasonable substitute model.
To further prove the concept of a time-dependent and quan-
titative release of Cm-p5 from the Fmoc-Met-OH reservoir 
gel, while maintaining its functional integrity (i.e., toxicity 
toward C. auris cells), the toxicity toward C. auris was exam-
ined using Cm-p5 that was released from the gel after different 
periods, representing a simple readout for activity (i.e., main-
tenance of integrity) and concentration of the released peptide. 
Already after 8 h, the diffusion of the peptide from the gel 
into the collected sample buffer approached the equilibrium 
at 9 µg mL–1 that was sufficient to eliminate ≈80% of the C. 
auris cells in these experiments in solution, proving that Cm-p5 
can be stored in the reservoir hydrogel layer and efficiently 
be quantitatively released from it into the environment in its 
active form (Figure 6C). The complete sandwich of both the 
Cm-p5 reservoir gel and the yeast affinity protein hydrogel was 
combined and its binding and killing functionality toward C. 
auris was proved in binding experiments to the final material 
and subsequent analysis using a microscopic assay based on 
resazurin to distinguish live from dead cells, since resazurin 
is exclusively metabolized to the fluorescent resorufin by living 
cells.[36] When loaded with Cm-p5, the sandwich hydrogel was 
able to significantly reduce the living C. auris cells even at con-
centrations below its MIC with 9 × 106 CFU at 10 µg mL−1 
and no detectable colony formation at 80 µg mL−1 compared 
to 1.3 × 108 CFU mL−1 measured for the unloaded gel by the 
Miles and Misra method.[37] (Figure 6D,E).
Macromol. Biosci. 2020, 2000005
Figure 4. Characterization of diffusion within and from composite materials. A) 3D printed mold for the preparation of a composite material. B) BSA/
THPC-hydrogel patch prepared in the mold containing Fmoc-Met-OH gel inlays. Fmoc-Met-OH gels were stained with bromophenol blue for better 
visualization. C) Time course of rhodamine B diffusion from the Fmoc-Met-OH inlays into the surrounding BSA/THPC-hydrogel visualized by confocal 
laser scanning microscopy (carrier layer penetration). D) Quantitative analysis of C) by FIJI software (version 1.51d). E) Release of rhodamine B from 
BSA/THPC-FmocMet-OH composite material depending on the BSA concentration (5%, 10%, or 15% w/v BSA) of the carrier layer. F) Cumulative 
release of rhodamine B from the composite material with different BSA concentrations in the carrier layer relative to the reached equilibrium concentra-
tion. G) Release rate (Δc/Δt) of the 10% BSA containing composite material calculated from panel (E).
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The final goal of our concept is the application of the 
hydrogel composites for wound care applications in which 
the establishment of severe and persisting infections is pro-
hibited by removal of C. auris cells from the wound surface 
immediately after infection and subsequent killing of the 
pathogen. As a first and simple experimental step to approach 
this goal, a model surface consisting of collagen was used 
to mimic a naturally occurring extracellular matrix for cell 
binding, on which the two-layer hydrogel system could be 
directly applied. In confocal laser scanning microscopy, C. 
auris appeared completely viable, when grown on the collagen 
without any hydrogel treatment (Figure 7A). In comparison 
C. auris cells from surface that was facing the two-layer sand-
wich hydrogel but without direct contact were significantly 
impaired (Figure 7B), suggesting that Cm-p5 was released 
from the BSA layer into the moist collagen surface and could 
thus also act on cells in close proximity to the application site. 
In contrast, cells with direct contact to the two-layer sandwich 
hydrogel were completely eradicated by its antifungal proper-
ties (Figure 7C).
3. Conclusion
In only one decade since its first isolation, the threat of 
C. auris infections has become ubiquitous in clinical environ-
ments and it is developing alarmingly due to newly described 
transmission between patients and spreading on surfaces 
in clinical environments.[5] Yeast cells can enter the blood-
stream causing fatal infections.[2] Prevention of such invasion 
through wounds is crucial already in early stages of surgical 
care and—in the case of multidrug-resistant pathogens such 
as C. auris—efficient and safe alternative drugs and novel 
concepts for their applications are urgently needed. We have 
reported the preparation and application of a functional two-
layer hydrogels providing various important features that 
enable their usage as surgical dressings: The bilayer hydro-
gels exhibit an attractive stability, functionalization with bio-
active peptides and proteins within each layer and diffusion 
characteristics, suitable for clinical wound care applications. 
Within few hours, an even distribution from the Fmoc-
Met-OH into the BSA/THPC hydrogel layer was observed. 
Macromol. Biosci. 2020, 2000005
Figure 5. Lectin B used for the binding of C. auris and for the decoration of BSA/THPC hydrogels for subsequent yeast immobilization. A) YFP-LecB 
binding to C. auris cells visualized by confocal laser scanning microscopy at an excitation wavelength of 514 nm. B) Functionalization of the affinity 
hydrogel with recombinant-purified YFP-LecB fusion protein at different concentrations for 2 h at 21 °C using 10 × 10−3 m bismaleimideoethane as a 
cross-linker. Gels were analyzed by CLSM at an excitation of 514 nm. Representative 50 × 50 µm areas (I, II, and III) were converted in 32-bit grayscale 
and fluorescence was quantified by FIJI software (version 1.51d). C) Binding of C. auris to affinity hydrogels, functionalized with increasing amounts 
of YFP-LecB as affinity and imaging molecule. Bound cells were visualized by light microscopy. D) Surface coverage of the affinity layer counted by FIJI 
software from panel (C).
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Consequently, for a two-layer sandwich hydrogel prepared 
for clinical application, the BSA/THPC layer would be ready 
for an immediate drug release, while the Fmoc-Met-OH 
layer would further provide a reservoir for the anti-infective 
agent. The BSA/THPC layer further significantly reduced the 
loading of the pathogen C. auris by selective cell capturing 
within the affinity layer of the gel followed by subsequent 
AMP-dependent inactivation within the therapeutic Fmoc-
Met-OH gel layer. In summary, this system paves the way for 
the topical treatment of multidrug-resistant C. auris species 
in medical wound care while keeping the load on the patient 
at a very low level.
Consequently, our results provide new avenues to protect 
patients from invasion by C. auris from infected wounds. Note-
worthy, our platform technology could also be extended to other 
anti-infective agents. For instance, the AMP Cm-p5 has shown 
activity against C. auris and thus represents a very promising 
lead structure to identify next-generation drugs also against 
other Candida infections. We believe that local application of 
such bilayer affinity hydrogels provides a valuable strategy to 
overcome contaminations and spreading of pathogens, which 
is a key concern in surgical environments.
4. Experimental Section
Fabrication of the Two-Layer Sandwich Hydrogel: The carrier hydrogel 
was obtained by mixing a 20% BSA solution in PBS with an equal 
volume of a 3.57 mg mL−1 THPC solution (Sigma-Aldrich, Steinheim 
am Albuch, Germany). The Fmoc-Met-OH hydrogel on the other hand 
was prepared by spontaneous fibril formation by self-assembly upon 
mixing a 100 mg mL−1 Fmoc-Met-OH solution in DMSO with PBS 
containing the desired concentrations of Cm-p5 as an AMP at a ratio 
of 1:8.[20,22] The sandwich resulting from these two different hydrogels 
can simply be formed by either precasting the Fmoc-Met-OH hydrogel 
and overlaying it with the protein hydrogel or vice versa mediated by its 
self-adhesive properties.
The affinity layer was generated by overlaying the carrier layer hydrogel 
with a 10 × 10−3 m bismaleimideoethane (Thermo Fisher Scientific, 
Waltham, MA, USA) solution in PBS for 16 h, two washing steps with 
PBS, and addition of recombinant purified YFP-LecB fusion protein[15] 
at different concentrations for 2 h at 21 °C. After a final washing step, 
Macromol. Biosci. 2020, 2000005
Figure 6. Antifungal activity of the peptide Cm-p5 against C. auris. A) The MIC determined by the broth microdilution method according to Clinical and 
Laboratory Standards Institute guidelines M27-A3 with additional spectrophotometrical measurements of the (optical) cell densities at 600 nm after 
24 h illustrated as Lambert–Pearson plot. B) Antifungal activity of Cm-p5 remained stable after incubation for 6 h, respectively, 12 h in different human 
blood serum concentrations. For the sake of clear illustration, all the marks for nonsignificance have been excluded and only the mentioned significance 
has been included. C) Release of the antifungal peptide Cm-p5 from a fibrillary 0.8% w/v Fmoc-Met-OH hydrogel loaded with peptide. Solid gels were 
overlaid with equal volumes of PBS and the supernatant was collected after given periods. Antifungal effects of Cm-p5 released from gels were analyzed 
by the Miles and Misra method. D) Elimination of C. auris bound to the sandwich hydrogel functionalized with 400 × 10−9 m YFP-LecB. Hydrogels were 
incubated with C. auris suspensions with 2 × 105 cells. After washing with PBS, cell viability was monitored measuring the conversion of resazurin to 
fluorescent resorufin by living cells by CLSM at an excitation wavelength of 561 nm. E) Fluorescence and thus the amount of living cells were quanti-
fied from a 32-bit greyscale image of the detected signal by FIJI software (version 1.51d). Viability was further monitored by Miles and Misra Method.
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Figure 7. Killing of C. auris on a collagen-based surface with respect to its spatial distribution relative to the composite hydrogel. C. auris cells were 
applied on a collagen-based layer mimicking extracellular matrix exposed in a wound after injury. The BSA/THPC-Fmoc-Met-OH composite hydrogel 
loaded with Cmp5 (12 µg mL–1) was applied directly onto the yeast with the BSA/THPC surface facing toward the collagen. Viability of C. auris was 
visualized using a resazurin live/dead assay and confocal laser scanning microscopy of fluorescent living cells. A) Living C. auris cells without any 
contact to the composite hydrogel (negative control). B) C. auris cells beneath but without direct contact to the composite hydrogel. C) C. auris cells 
directly under and with close contact to the composite hydrogel show no viability after 4 h.
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gels were analyzed by controlled low strength material (CLSM) at an 
excitation of 514 nm. Representative 50 × 50 µm areas (I, II, and III) 
were converted in 32-bit grayscale and fluorescence was quantified by 
FIJI software (version 1.51d).[28]
Rheometry: The rheological properties of the two-layer hybrid 
hydrogel were investigated on a Kinexus Pro rotational rheometer 
(Malvern, Malvern, Worcestershire, UK) with a parallel plate geometry 
in triplicates. The gelation time of the Fmoc-Met-OH and the BSA/
THPC-hydrogel was monitored by measuring the increase of the elastic 
shear modulus at a defined strain of 1% at 25 °C and a frequency of 
0.1 Hz. The characterization of the final sandwich hydrogel system 
toward mechanical stress was, therefore, performed with gels after 
16 h cross-linking to guarantee completion of the carrier hydrogel 
formation as the limiting step in the production of the fully functional 
biomaterial. Subsequently, the mechanical stability of single gel layers 
and the complete composite gels was measured upon submission to an 
oscillatory strain up to 300% and a preload of 0.2 N using pregelled gels. 
The frequency was thereby kept constant at 1 Hz and the temperature 
at 25 °C.
Electron Microscopy: The hydrogels were analyzed by cryo scanning 
electron microscopy, as described previously.[23] In short, the composite 
material was incubated in 30% isopropanol for 1 h. To preserve the 
native structure, samples from each layer were excised from the 
composite material, transferred to low-mass aluminum planchettes, and 
frozen under high pressure (Engineering Office M. Wohlwend GmbH, 
Sennwald, Switzerland). The gels were then transferred into a freeze 
etching device (BAF300, Bal-Tec, Principality of Lichtenstein) and dried 
at –90 °C for 30 min and subsequently coated with a 3 mm platinum 
layer. Analysis was performed with a cryo-stage Gatan 626 (Gatan-Inc., 
Pleasanton, California, USA) at a temperature of –100 °C and an 
acceleration voltage of 10 kV.
Adhesion Test: The adhesion of the final composite material was 
tested on pork skin obtained from a local butcher (EDEKA Center Ulm-
Lehr, Ulm, Germany).
Diffusion Analysis: For the analysis of diffusion within the hydrogel 
system, a casting mold was modeled with the 3D modeling software 
SketchUp (Trimble Navigation Ltd., Sunnyvale, CA, USA) and 3D 
printed with a Wanhao Duplicator I3 (Wanhao, Jinhua, China) using 
polylactic acid filaments (Prima Filaments, Malmö, Sweden). A BSA/
THPC hydrogel was then cast into this template and cross-linked. The 
resulting cavities within the BSA/THPC hydrogel were then filled with the 
Fmoc-Met-OH hydrogel. The diffusion in such a patch could be easily 
monitored by loading the Fmoc-Met-OH gel with 1 µg mL−1 rhodamine 
B as amphiphilic model chemical compound.[12,30] For the analysis of 
rhodamine B release from the two-layer sandwich hydrogel, the hydrogel 
system was overlayed with 2 mL PBS. The 2 mL Fmoc-Met-OH layer 
was again loaded with 1 µg mL–1 rhodamine and had a 1 mL BSA/
THPC layer with a final BSA concentration of 5%, 10%, and 15%. The 
release was then monitored by measuring the increase of fluorescence 
in the supernatant with a Tecan Infinite M200 (Tecan Group, Männedorf, 
Switzerland) at an excitation wavelength of 535 nm and a emission 
wavelength of 595 nm. Concentrations were determined by a standard 
curve of different rhodamine B concentrations and illustrated as the 
cumulative release of the individual composite hydrogels relative to their 
reached equilibrium concentration.
The release rate was defined as the time-dependent increase of 
rhodamine B concentration in the supernatant (Δc/Δt) and was further 
determined only for the further used 10% BSA/THPC hydrogel.
Synthesis of Cm-p5: The antifungal peptide Cm-p5 was synthesized by 
the solid-phase method using 9-fluorenyl-methoxycarbonyl chemistry and 
purified by reverse phase high performance liquid chromatography to 
98% purity using an acetonitrile/H2O-TFA gradient. Purity was confirmed 
by ion spray mass spectrometry (Micromass, Manchester, UK).[12]
C. auris Growth and MIC Determination: C. auris (DSMZ-No. 21092, 
CBS 10913, JCM 15448)[1] was grown in YPD medium (1% w/v yeast 
extract, 2% w/v peptone, 2% w/v glucose) at 37 °C with orbital shaking 
at 150 rpm. Minimal inhibitory concentration assays were performed in 
RPMI-1640 medium supplemented with L-glutamine (Thermo Fisher 
Scientific, Waltham, MA, USA) according to the broth microdilution 
method of the Clinical and Laboratory Standards Institute guidelines 
M27-A3 with additional spectrophotometrical measurements of the 
(optical) cell densities at 600 nm after 24 h and MIC determination by a 
Lambert–Pearson plot.[34,38]
LecB Binding to C. auris: The immobilization of pathogens within the 
hydrogel material was accomplished via a recombinant fusion between 
lectin and YFP as a reporter protein domain.[15] Its binding toward C. 
auris was tested by incubating 2 × 103 (standardized in 20 µL) cells in a 
250 × 10−9 m YFP-LecB solution, washing in PBS (2.6 × 10−3 m KCl, 1.5 
× 10−3 m KH2PO4, 8 × 10−3 m Na2HPO4, 137 × 10−3 m NaCl, pH 7), and 
subsequent visualization by confocal laser scanning microscopy.
Immobilization of C. auris: Binding of C. auris cells to the affinity 
layer, functionalized with different concentrations (0–400 × 10−9 m) of 
YFP-LecB as a binding and imaging molecule, was investigated by the 
addition of 200 µL cell suspension (106 cells mL−1) and incubation for 
60 min at 21 °C. After washing twice with 100 µL PBS, bound cells were 
observed by light microscopy.
Stability of Cm-p5 in Human Blood Serum: Cm-p5 (40 µg mL−1) was 
incubated at 25 °C with increasing amounts of human AB serum (Sigma-
Aldrich, St. Louis, Missouri, USA). After 6 h, respectively, 12 h C. auris in 
RPMI-1640 medium was added to a final cell number of 2 × 103 (final 
Cm-p5 concentration 20 µg mL−1) and incubated for 24 h at 37 °C. The 
activity of Cm-p5 was determined from the growth of C. auris relative to 
the growth in human serum containing medium in the absence of Cm-p5.
Antifungal Activity of Cm-p5 Released from Hydrogels: Fmoc-Met-OH 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany) 10% w/v dissolved in 
DMSO and Cm-p5 (1.5 mg mL−1 in DMSO) were added to PBS to a final 
Fmoc-Met-OH concentration of 0.8% w/v and a peptide concentration 
of 80 µg mL−1. Solid gels were overlaid with equal volumes of PBS and 
the supernatant was collected after given periods. Antifungal effects 
of Cm-p5 released from gels were analyzed by the Miles and Misra 
method.[37] The final composite hydrogel sandwich was obtained 
by casting BSA hydrogels on top of Cm-p5 Fmoc-Met-OH hydrogel 
reservoirs (concentrations 0–80 µg mL−1) and functionalized with 
400 × 10−9 m YFP-LecB. These hydrogels were incubated with C. auris 
suspensions with 2 × 105 cells in 200 µL for 2 h at 21 °C. After washing 
with PBS, the sandwich hydrogels were incubated with 0.1 mg mL−1 
resazurin (Sigma-Aldrich) for 1 h at 21 °C, cells were washed with PBS, 
and cell viability was monitored measuring the conversion of resazurin to 
fluorescent resorufin by living cells by CLSM at an excitation wavelength 
of 561 nm. The fluorescence and thus the amount of living cells were 
quantified from a 32-bit grayscale image of the detected signal by FIJI 
software (version 1.51d). Additionally, viability was also investigated by 
the Miles and Misra method after releasing bound cells from the affinity 
layer with 200 µL 20 × 10−3 m mannose in PBS.
Collagen Surface Substrate Model: A model for wound care application 
was composed of collagen, which was gelated by mixing 150 µL of 1 mg 
mL−1 stock solution of collagen from rat tail in PBS with 1.5 µL of 1 m 
NaOH in eight-well Ibidi µ-Slide (ibidi, Martinsried, Germany). Gelation 
was performed for 1 h at 30 °C. To expose this layer toward the yeast, 
200 µL of a C. auris culture in YPD medium[39] containing 2 × 105 C. 
auris cells was loaded onto the collagen surface. The composite hydrogel 
loaded with Cm-p5 (12 µg mL−1) was placed on top of the collagen layer 
by transferring it from the casting mold with tweezers with the affinity 
layer facing the cells. After 2 h, 10 µL of a sterile 0.1% resazurin solution 
were added to the C. auris cells. The viability of C. auris was analyzed by 
confocal laser scanning microscopy after 2 h at 561 nm, as described 
before, with respect to the position of the cells in this artificial wound 
immediately beneath or in close contact to the antifungal wound dressing.
Statistical Analysis: Statistical analysis was performed by a paired 
t-test.
Acknowledgements
C.F. and H.R. contributed equally to this work. This work was supported 
by the in the framework of “Bioinspired Material Synthesis”, the Ministry 
www.advancedsciencenews.com www.mbs-journal.de
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim2000005 (11 of 11)
of Science, Research and Arts of the state of Baden-Württemberg in 
the framework of the PhD program: pharmaceutical biotechnology, the 
Federal Ministry of Education and Research (BMBF-WTZ-DLR, Germany-
Cuba, 2018–2020; BMBF/DLR 01DN18009; BMBF, Biotechnologie 
2020+ Basistechnologien: Projekt SeleKoM), the European Union project 
“Horizon 2020” (No. 686271) in the framework “AD-gut,” and the 
Collaborative Research Center (CRC1279).
Conflict of Interest
The authors declare no conflict of interest.
Keywords
Candida auris, compound encapsulation, drug delivery, intrinsic 
antimicrobial activity, multicomponent hydrogels
Received: January 7, 2020
Revised: February 7, 2020
Published online: 
[1] K. Satoh, K. Makimura, Y. Hasumi, Y. Nishiyama, K. Uchida, 
H. Yamaguchi, Microbiol. Immunol. 2009, 53, 41.
[2] S. E. Morales-López, C. M. Parra-Giraldo, A. Ceballos-Garzón, 
H. P. Martínez, G. J. Rodríguez, C. A. Álvarez-Moreno, 
J. Y. Rodríguez, Emerg. Infect. Dis. 2017, 23, 162.
[3] S. R. Lockhart, K. A. Etienne, S. Vallabhaneni, J. Farooqi, 
A. Chowdhary, N. P. Govender, A. L. Colombo, B. Calvo, 
C. A. Cuomo, C. A. Desjardins, E. L. Berkow, M. Castanheira, 
R. E. Magobo, K. Jabeen, R. J. Asghar, J. F. Meis, B. Jackson, 
T. Chiller, A. P. Litvintseva, Clin. Infect. Dis. 2017, 64, 134.
[4] J. Osei Sekyere, MicrobiologyOpen 2018, 7, e00578.
[5] C. T. Piedrahita, J. L. Cadnum, A. L. Jencson, A. A. Shaikh, 
M. A. Ghannoum, C. J. Donskey, Infect. Control Hosp. Epidemiol. 
2017, 38, 1107.
[6] Centers for Disease Control and Prevention, Clinical Alert to U.S. 






[8] T. Ciociola, L. Giovati, S. Conti, W. Magliani, C. Santinoli, 
L. Polonelli, Future Med. Chem. 2016, 8, 1413.
[9] M. Rautenbach, A. M. Troskie, J. A. Vosloo, Biochimie 2016, 130, 132.
[10] A. Hollmann, M. Martinez, P. Maturana, L. C. Semorile, 
P. C. Maffia, Front. Chem. 2018, 6, 204.
[11] F. E. M. Vicente, M. González-Garcia, E. Diaz Pico, E. Moreno-
Castillo, H. E. Garay, P. E. Rosi, A. M. Jimenez, J. A. Campos-
Delgado, D. G. Rivera, G. Chinea, R. C. L. R. Pietro, S. Stenger, 
B. Spellerberg, D. Kubiczek, N. Bodenberger, S. Dietz, F. Rosenau, 
M. W. Paixão, L. Ständker, A. J. Otero-González, ACS Omega 2019, 
4, 19081.
[12] C. López-Abarrategui, C. McBeth, S. M. Mandal, Z. J. Sun, 
G. Heffron, A. Alba-Menéndez, L. Migliolo, O. Reyes-Acosta, 
M. García-Villarino, D. O. Nolasco, R. Falcão, M. D. Cherobim, 
S. C. Dias, W. Brandt, L. Wessjohann, M. Starnbach, O. L. Franco, 
A. J. Otero-González, FASEB J. 2015, 29, 3315.
[13] A. Francesko, P. Petkova, T. Tzanov, Curr. Med. Chem. 2017.
[14] E. A. Kamoun, E. R. S. Kenawy, X. Chen, J. Adv. Res. 2017, 8, 
217.
[15] N. Bodenberger, D. Kubiczek, D. Halbgebauer, V. Rimola, S. Wiese, 
D. Mayer, A. A. Rodríguez Alfonso, S. Stenger, F. Rosenau, Biomac-
romolecules 2018, 19, 2472.
[16] A. Khan, M. Xu, T. Wang, C. You, X. Wang, H. Ren, H. Zhou, 
A. Khan, C. Han, P. Li, Biosci. Rep. 2019, 39, BSR20190504.
[17] G. Yang, T. Huang, Y. Wang, H. Wang, Y. Li, K. Yu, L. Dong, J. Bio-
mater. Sci., Polym. Ed. 2018, 29, 1812.
[18] N. Bodenberger, D. Kubiczek, L. Trösch, A. Gawanbacht, 
S. Wilhelm, D. Tielker, F. Rosenau, Sci. Rep. 2017, 7.
[19] D. Tielker, F. Rosenau, K. M. Bartels, T. Rosenbaum, K. E. Jaeger, 
BioTechniques 2006, 41, 327.
[20] E. R. Draper, K. L. Morris, M. A. Little, J. Raeburn, C. Colquhoun, 
E. R. Cross, T. O. McDonald, L. C. Serpell, D. J. Adams, CrystEng-
Comm 2015, 17, 8047.
[21] S. Atefyekta, M. Pihl, C. Lindsay, S. C. Heilshorn, M. Andersson, 
Acta Biomater. 2019, 83, 245.
[22] V. Singh, K. Snigdha, C. Singh, N. Sinha, A. K. Thakur, Soft Matter 
2015, 11, 5353.
[23] S. Brien, P. Prescott, N. Bashir, H. Lewith, G. Lewith, Osteoarthritis 
Cartilage 2008, 16, 1277.
[24] C. Chung, K. J. Lampe, S. C. Heilshorn, Biomacromolecules 2012, 13, 
3912.
[25] M. Fürsatz, M. Skog, P. Sivlér, E. Palm, C. Aronsson, A. Skallberg, 
G. Greczynski, H. Khalaf, T. Bengtsson, D. Aili, Biomed. Mater. 
2018, 13, 025014.
[26] H. Joodaki, M. B. Panzer, J. Eng. Med. 2018, 232, 323.
[27] I. Levental, P. C. Georges, P. A. Janmey, Soft Matter 2007, 3, 299.
[28] J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, 
T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, 
J. Y. Tinevez, D. J. White, V. Hartenstein, K. Eliceiri, P. Tomancak, 
A. Cardona, Nat. Methods 2012, 9, 676.
[29] N. Bodenberger, P. Paul, D. Kubiczek, P. Walther, K. E. Gottschalk, 
F. Rosenau, ChemistrySelect 2016, 1, 1353.
[30] T. Osakai, H. Yamada, H. Nagatani, T. Sagara, J. Phys. Chem. C 
2007, 111, 9480.
[31] N. Bodenberger, D. Kubiczek, I. Abrosimova, A. Scharm, F. Kipper, 
P. Walther, F. Rosenau, Biotechnol. Rep. 2016, 12, 6.
[32] N. Sharon, H. Lis, Science 1989, 246, 227.
[33] M. Monsigny, R. Mayer, A. C. Roche, Carbohydr. Lett. 2000, 4, 35.
[34] R. J. W. Lambert, J. Pearson, J. Appl. Microbiol. 2000, 88, 784.
[35] K. F. Cutting, Br. J. Community Nurs. 2003, 8, S4.
[36] T. L. Riss, R. A. Moravec, A. L. Niles, S. Duellman, H. A. Benink, 
T. J. Worzella, L. Minor, Assay Guid. Man. Internet 2013, 114, 
785.
[37] A. A. Miles, S. S. Misra, J. O. Irwin, J. Hyg. 1938, 38, 732.
[38] CLSI, Reference method for broth dilution antifungal susceptibility 
testing of yeasts; approved standard, 3rd ed., CLSI, Wayne, PA 2008.
[39] I. Corbacho, F. Teixidó, R. Velázquez, L. M. Hernández, I. Olivero, 
A. van Leeuwenhoek, Int. J. Gen. Mol. Microbiol. 2011, 99, 591.
Macromol. Biosci. 2020, 2000005
